Searched over 200M research papers
10 papers analyzed
These studies suggest that walking can help reduce blood pressure, with effectiveness varying based on age, intensity, duration, and additional lifestyle factors.
17 papers analyzed
20 papers analyzed
Walking is a simple, low-cost form of physical activity that is accessible to most people. It has been widely recommended as a lifestyle modification to help manage hypertension, a major risk factor for cardiovascular diseases. This article synthesizes findings from multiple studies to determine the effectiveness of walking in reducing blood pressure.
Several studies provide moderate-certainty evidence that walking can reduce systolic blood pressure (SBP). A comprehensive review of 73 trials involving 5763 participants found that walking interventions led to a mean reduction in SBP of 4.11 mmHg. This effect was consistent across different age groups and sexes, with reductions observed in participants aged 40 years and under (4.41 mmHg), 41 to 60 years (3.79 mmHg), and over 60 years (4.30 mmHg).
A meta-analysis of 16 studies with 650 subjects also reported significant decreases in resting SBP by approximately 3 mmHg. Another meta-analysis of 24 randomized controlled trials confirmed that walking interventions increased aerobic fitness and decreased SBP in previously sedentary adults.
The evidence for the impact of walking on diastolic blood pressure (DBP) is less robust but still promising. The same review of 73 trials found low-certainty evidence suggesting that walking reduces DBP by 1.79 mmHg. This reduction was observed across different age groups and sexes, with the most significant reductions in participants aged 40 years and under (3.01 mmHg).
A systematic review of 27 randomized controlled trials found that walking interventions were more effective in studies with larger sample sizes and those employing moderate to high-intensity walking over longer periods. This review supports the notion that walking can help control DBP, although the optimal intensity and duration of walking programs remain subjects for further research.
The effectiveness of walking on blood pressure appears to be influenced by the intensity and duration of the activity. Moderate-intensity walking has been shown to produce significant reductions in both SBP and DBP. For instance, a study involving postmenopausal women found that walking 3 km per day for 24 weeks reduced SBP by 11 mmHg, although no significant change was observed in DBP.
An e-health pilot study involving sedentary older adults with hypertension demonstrated that increasing daily steps by 3000 steps per day significantly reduced both SBP and DBP over a 20-week period. This suggests that even modest increases in daily walking can have beneficial effects on blood pressure.
Walking has also been shown to reduce resting heart rate, which is another important cardiovascular risk factor. A review of 73 trials found low-certainty evidence that walking reduces heart rate by 2.76 beats per minute. This reduction was more pronounced in studies involving light-intensity walking or simple resistance activities.
The collective evidence suggests that walking is an effective intervention for reducing both systolic and diastolic blood pressure, particularly when performed at moderate intensity and over extended periods. While the certainty of evidence varies, the overall trend indicates that walking can be a valuable component of hypertension management. Future research should focus on optimizing walking programs to maximize their blood pressure-lowering effects.
Most relevant research papers on this topic